Pillstats
Rx only · Tablet, Film Coated, Extended Release · Oral

Etodolac

Etodolac

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)24605
US makers8 labelers
Packages43
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.297$0.595$0.892$1.19Dec 2025Apr 2026Jul 2026
$0.941
Latest avg · Jul 22, 2026
-8%
Since Dec 17, 2025
8
Active US suppliers
70%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1693385076762025 Q12025 Q22025 Q32025 Q42026 Q1
402
Rx · 2026 Q1
15K
Units dispensed
-32%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Pharmaceuticals USA Inc.unknown15SUPPLYING
Zydus Lifesciences Limitedunknown15SUPPLYING
Proficient Rx LPunknown6SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown3SUPPLYING
ADVANCED RX PHARMACY OF TENNESSEE, LLCunknown1SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING
St. Mary's Medical Park Pharmacyunknown1SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.